Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Application Segment | Drug Discovery, Molecular Modelling, Chemical Screening, Regulatory and Decision-Making, Other Applications |
| Industry Segment | Pharmaceuticals, Cosmetics, Environmental, Food and Beverages |
| Regions & Countries |
|
|---|
Increasing investment in pharmaceutical R&D Increased demand for improved computational techniques in drug discovery Growth of the biotechnology and healthcare industries Concentrate on individualized medicine. Need for efficient and cost-effective drug design solutions
Stringent regulatory requirements Lack of skilled professionals in computational chemistry
Integration of artificial intelligence and machine learning technologies Increasing adoption of molecular modelling techniques
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
In the QSAR market's competitive landscape, many influential players are providing QSAR services and software solutions. Schrödinger, Accelrys (now owned by Dassault Systèmes), Biovia, and Chemical Computing Group are leading companies in the QSAR market, providing advanced computational tools for drug discovery and chemical modeling. These organizations provide diverse software solutions that enable researchers to predict molecular properties and biological activities of compounds, assisting in the drug development process.
May 2021, Intertek bought SAI Global's Assurance and Standards Business Units
(Source: https://www.intertek.com/news/2021/05-13-intertek-acquires-sai-global-assurance/)
November 2024: The Royal Free London NHS Foundation Trust formed a five-year relationship with DeepMind Technologies (Google), with the idea that the latter would assist the former in developing treatments for acute kidney injury. The 100,000 Genomes Project of the United Kingdom is an international project that leverages Al and data from individuals with rare diseases in the National Health Service. Roche, Merck, and Biogen are also participating in the program.
(Source: https://www.digitalhealth.net/2016/11/google-deepmind-and-royal-free-in-five-year-deal/)
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| ProtoQSAR SL | ••• | ••• | ••• | ••• |
| Intertek Group Plc | ••• | ••• | ••• | ••• |
| Dassault Systems SE | ••• | ••• | ••• | ••• |
| Bibra Toxicology Advice & Consulting Ltd | ••• | ••• | ••• | ••• |
| Laboratory Corporation of America Holdings | ••• | ••• | ••• | ••• |
| LATHAM BIOPHARM GROUP | ••• | ••• | ••• | ••• |
| NSF INTERNATIONAL | ••• | ••• | ••• | ••• |
| Creative Biolabs | ••• | ••• | ••• | ••• |
| QSAR LAB SP. Z O | ••• | ••• | ••• | ••• |
| Covance Inc. | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →According to Cognitive Market Research, the global Quantitative Structure-Activity Relationship market size is USD 1658.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.00% from 2024 to 2031.
A quantitative Structure-Activity relationship (QSAR) is a computer or mathematical modeling approach that identifies relationships between biological activities and structural features of chemical substances. It aims to coerce chemical structure with an activity utilizing statist techniques. The QbAll models are useful for a variety of purposes, including predicting the impacts of untested compounds. They also aid in the prioritization of desired biological activities as an in silico methodology, reducing the number of candidate chemicals that must be evaluated in vivo. In the QSAR market, various factors contribute to its growth. The increasing focus on drug discovery and development in the pharmaceutical industry is a major driver for the QSAR market. QSAR models are crucial for predicting the biological activity of new compounds, assisting in the development of more effective and safer drugs. Furthermore, the increasing use of computational techniques in pharmaceutical research and the need for cost-effective and time-saving solutions also drive the demand for QSAR services and software.
For instance, in May 2024, Cresset collaborated with Enamine, a prominent producer of chemical building blocks and drug discovery services, to create novel solutions for the early drug development process.
Conclusion
Conclusion
★ Reviews
Rate this report
| Application | Drug Discovery, Molecular Modelling, Chemical Screening, Regulatory and Decision-Making, Other Applications |
| Industry | Pharmaceuticals, Cosmetics, Environmental, Food and Beverages |
| List of Competitors | ProtoQSAR SL, Intertek Group Plc, Dassault Systems SE, Bibra Toxicology Advice & Consulting Ltd, Laboratory Corporation of America Holdings, LATHAM BIOPHARM GROUP, NSF INTERNATIONAL, Creative Biolabs, QSAR LAB SP. Z O, Covance Inc. |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Quantitative Structure Activity Relationship Qsar Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Quantitative Structure Activity Relationship Qsar Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global quantitative structure activity relationship qsar market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.